| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/03/2005 | CA2128215C Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy |
| 04/28/2005 | WO2005038031A1 Expression vector for secreting antibody fragment using e. coli signal sequence and method for mass-producing antibody fragment |
| 04/28/2005 | WO2005038019A1 Method for producing gamma-carboxylated proteins |
| 04/28/2005 | WO2005038017A2 Prevention of incorporation of non-standard amino acids into protein |
| 04/28/2005 | WO2005038002A2 Site-specific incorporation of redox active amino acids into proteins |
| 04/28/2005 | WO2005037870A1 Antibody and use of the same |
| 04/28/2005 | WO2005037864A1 Novel protein and production process and use thereof |
| 04/28/2005 | WO2005037314A1 Method for generating antibodies |
| 04/28/2005 | WO2005037311A1 Pharmaceutical compositions for therapeutic use |
| 04/28/2005 | WO2005010165A3 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof |
| 04/28/2005 | WO2005010155A3 Methods of decoupling reaction scale and protein synthesis yield in batch mode |
| 04/28/2005 | WO2004076618A8 Genetically modified non-human mammals and cells |
| 04/28/2005 | WO2004050833A3 Glyceraldehyde 3-phosphate dehydrogenase-s(gapds), a glycolytic enzyme expressed only in male germ cells,is a target for male contraception |
| 04/28/2005 | WO2004032839A3 Methods and formulations comprising agonists and antagonists of nuclear hormone receptors |
| 04/28/2005 | WO2003044170A3 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 04/28/2005 | WO2002072013A8 Method of treating malignancies through induction of blood immune responses |
| 04/28/2005 | US20050091715 Cacao endoproteinases and production of cocoa flavor from same |
| 04/28/2005 | US20050090648 Humanized antibodies |
| 04/28/2005 | US20050090646 cytotoxic fusion proteins that are useful for selectively killing endothelial cells in blood vessels that feed tumors |
| 04/28/2005 | US20050090644 Production of secreted polypeptides |
| 04/28/2005 | US20050090001 Cell lines and methods for producing proteins |
| 04/28/2005 | US20050089974 Fermentative production of d-hydroxyphenylglycine and d-phenylglycine |
| 04/28/2005 | US20050089970 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use |
| 04/28/2005 | US20050089967 Mutant tyrosine repressor gene and utilization thereof |
| 04/28/2005 | US20050089957 Chimera; immunoglobuins; antibodies; host cells; immunohistochemistry |
| 04/28/2005 | US20050089951 Method for labeled amidation of biological molecule and method for analyzing biological molecule |
| 04/28/2005 | US20050089941 Drug screening; SCFV fragments; polyacrylamide gel electrophoresis |
| 04/28/2005 | US20050089933 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 04/28/2005 | US20050089911 87 human secreted proteins |
| 04/28/2005 | US20050089887 Novel human ion channel proteins |
| 04/28/2005 | US20050089868 Modulators of tissue regeneration |
| 04/28/2005 | US20050089855 Expression vector comprising nucleotide sequences coding glycine transport protein for use in identifying modulator for treatment and prevention of nervous system and psychiatric disorders |
| 04/28/2005 | US20050089849 In vivo urea cycle enzyme genes, transformation for protein expression |
| 04/28/2005 | US20050089843 Polyclonal antibody specific for mannose-terminated viral envelope protein for use in detection and prevention of viral diseases |
| 04/28/2005 | US20050089841 Induction of a Th1-like response in vitro |
| 04/28/2005 | US20050089538 Carcinoembryonic antigen (CEA); administering a humanized Class III, anti-CEA, monoclonal antibody to treat cancer; complementarity-determining regions (CDR) of given amino acid sequences; diagnostic and therapeutic conjugates; transformed cells |
| 04/28/2005 | US20050089532 Method of protein production using mitochondrial translation system |
| 04/28/2005 | US20050089526 Monomeric unit of the complex containin HIV-1 gp120 and HIV-1 gp41, (ii) the gp4l has one or more mutations in its N-terminal helix, and (iii) the gp120 and gp41 are bound to each other by a disulfide bond between a cysteine residue introduced into the gp120 and a cysteine residue introduced into gp41 |
| 04/28/2005 | US20050089520 Antibody stimulating il-ira production |
| 04/28/2005 | US20050089519 Bispecific anti-cd19x anti-cd16 antibodies and uses thereof |
| 04/28/2005 | CA2543447A1 Antibody and use of the same |
| 04/28/2005 | CA2543406A1 Mutants of human chondromodulin-i (hchm-i) and uses thereof in inhibiting angiogenesis and bone resorption |
| 04/28/2005 | CA2542680A1 Pharmaceutical compositions for therapeutic use |
| 04/28/2005 | CA2541764A1 Method for producing gamma-carboxylated proteins |
| 04/28/2005 | CA2541166A1 Site-specific incorporation of redox active amino acids into proteins |
| 04/28/2005 | CA2539996A1 Prevention of incorporation of non-standard amino acids into protein |
| 04/27/2005 | EP1526141A2 MHC complexes and uses thereof |
| 04/27/2005 | EP1526140A1 Novel potassium-dependent sodium-calcium exchanger |
| 04/27/2005 | EP1525473A2 Method and device for protein delivery into cells |
| 04/27/2005 | EP1525323A2 Pgc-beta, a novel pgc-1 homologue and uses therefor |
| 04/27/2005 | EP1525318A1 Method for enhancing yield of recombinant protein production from plants |
| 04/27/2005 | EP1525313A1 Canine respiratory coronavirus (crcv) spike protein, polymerase and hemaggllutinin/esterase |
| 04/27/2005 | EP1525305A2 Methods and compositions for in vitro synthesis of biological macromolecules in a cell-free system enriched with atp-sulfurylase |
| 04/27/2005 | EP1412513A4 Phosphate limited inducible promoter and a bacillus expression system |
| 04/27/2005 | EP1373570A4 Improved in vitro synthesis system |
| 04/27/2005 | EP1373295A4 Regulatable growth of filamentous fungi |
| 04/27/2005 | EP1358320A4 68730 and 69112 protein kinase molecules and uses therefor |
| 04/27/2005 | EP1253932B1 Botulinum toxin pharmaceutical compositions |
| 04/27/2005 | EP1127104A4 Method for the massive culture of cells producing recombinant human erythropoietin |
| 04/27/2005 | EP1016709B1 Lactobacillus helveticus bacterium having high capability of producing tripeptide, fermented milk product, and process for preparing the same |
| 04/27/2005 | EP0939818B1 Recombinant toxin fragments |
| 04/27/2005 | EP0877801B1 Morphological mutants of filamentous fungi |
| 04/27/2005 | EP0759981B1 A method of cultivating bacteria producing proteins that are expressed in a temperature regulated manner |
| 04/27/2005 | EP0743983B1 Mammalian thymokine genes |
| 04/27/2005 | CN1610754A Enzymes having dehalogenase activity and methods of use thereof |
| 04/27/2005 | CN1610748A Recombinant MVA capable of expressing structural HCV antigens |
| 04/27/2005 | CN1610743A Gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 04/27/2005 | CN1610737A Phenotypic screen of chimeric proteins |
| 04/27/2005 | CN1610697A E type hepatitis virus monoclonal antibody or its conjugated active fragment and use thereof |
| 04/27/2005 | CN1610696A Antibodies that immunospecifically bind to TRAIL receptors |
| 04/27/2005 | CN1610695A Human monoclonal antibodies to epidermal growth factor receptor (EGFR) |
| 04/27/2005 | CN1610556A Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 04/27/2005 | CN1609229A Prepn process of plant metallothionein dimer |
| 04/27/2005 | CN1609228A Method for preparing insect cell extract for synthesizing cell-free protein, the insect cell extract and method for synthesizing the cell-free protein by using the insect cell extract |
| 04/27/2005 | CN1609214A Expression of recombinant ox growth hormone in pichia pastoris |
| 04/27/2005 | CN1609201A Gene engineering cell line of high expression recombinant protein and high-yield baculovirus |
| 04/27/2005 | CN1609197A High-yield reverse immunization for finding tumor specific antigen and tumor specific antigen determinant |
| 04/27/2005 | CN1609196A High-yield T lymphocyte cloning technology for finding tumor specific antigen and tumor specific antigen determinant |
| 04/27/2005 | CN1198936C Alzheimer's disease secretase |
| 04/27/2005 | CN1198932C Streptococcus pneumoniae antigens |
| 04/27/2005 | CN1198931C MOraxella catarrhalis BASB034 polypeptides and uses thereof |
| 04/27/2005 | CN1198929C Antibodies against interferon alpha/beta receptor |
| 04/27/2005 | CN1198928C High temperature resistant ribosomal protein L-15 gene and its polypeptide encoded by it and preparing process |
| 04/27/2005 | CN1198924C Expression cloning in filamentous fungi |
| 04/27/2005 | CN1198845C Monoclonal antibody inducing programming apoptosis |
| 04/27/2005 | CN1198844C Process of high purity albumin production |
| 04/27/2005 | CN1198836C Nucleic acids encoding G-protein coupled receptor involved in sensory |
| 04/27/2005 | CN1198648C High affinity human monoclonal antibodies specific for RSV F-protein |
| 04/27/2005 | CN1198642C Pharmaceutical application of mammal cell kinetin synthetic inhibitory factor |
| 04/26/2005 | US6884879 Anti-VEGF antibodies |
| 04/26/2005 | US6884620 Genetic engineering |
| 04/26/2005 | US6884618 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 04/26/2005 | US6884616 DNA-construct for the tissue-specific expression of a blood coagulation factor |
| 04/26/2005 | US6884614 Comprises nucleotide sequences coding sucrose transport modulating enzymatic polypeptide for use in preparing animal feeds, cosmetic and foods |
| 04/26/2005 | US6884576 Genetically engineered cell for use in the diagnosis, prevntion and treatment of viral diseases |
| 04/26/2005 | US6884574 Methods of identifying agents which inhibit GPR-9-6 |
| 04/26/2005 | CA2253871C Ret ligand (retl) for stimulating neural and renal growth |
| 04/26/2005 | CA2165954C Prostaglandin receptor fp and dna encoding it |
| 04/21/2005 | WO2005035778A1 PROCESS FOR PRODUCING ANTIBODY COMPOSITION BY USING RNA INHIBITING THE FUNCTION OF α1,6-FUCOSYLTRANSFERASE |
| 04/21/2005 | WO2005035777A1 Dna vaccines against tumor growth and methods of use thereof |